Daiwa Securities Group
TARS icon

Daiwa Securities Group’s Tarsus Pharmaceuticals TARS Stock Holding History

Daiwa Securities Group’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-137
Closed -$11K – 1419
2025
Q4 		$11K Hold
137
– – ﹤0.01% 1182
2025
Q3 		$8K Hold
137
– – ﹤0.01% 1174
2025
Q2 		$6K Hold
137
– – ﹤0.01% 1152
2025
Q1 		$7K Buy
137
+30
+28% +$1.48K ﹤0.01% 1116
2024
Q4 		$6K Hold
107
– – ﹤0.01% 1156
2024
Q3 		$4K Hold
107
– – ﹤0.01% 1188
2024
Q2 		$3K Hold
107
– – ﹤0.01% 1237
2024
Q1 		$4K Hold
107
– – ﹤0.01% 1228
2023
Q4 		$2K Hold
107
– – ﹤0.01% 1281
2023
Q3 		$2K Hold
107
– – ﹤0.01% 1227
2023
Q2 		$2K Hold
107
– – ﹤0.01% 1247
2023
Q1 		$1K Hold
107
– – ﹤0.01% 1283
2022
Q4 		$2K Buy
+107
New +$1.77K ﹤0.01% 1240

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Daiwa Securities Group's TARS Position: Q1 2026 in Review

Daiwa Securities Group sold out of Tarsus Pharmaceuticals (TARS) in Q1 2026, closing a stake of 137 shares — an estimated $11K sold.

Daiwa Securities Group first reported a position in TARS in Q4 2022 and held it in 13 quarters. The position peaked at $11K in Q4 2025. 253 funds tracked by Wall St. Rank hold TARS as of Q1 2026.

  • Daiwa Securities Group reported no remaining Tarsus Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 137 Tarsus Pharmaceuticals shares in Q1 2026, an estimated $11K.
  • Daiwa Securities Group first reported a position in Tarsus Pharmaceuticals in Q4 2022 and held it in 13 quarters.
  • Daiwa Securities Group's Tarsus Pharmaceuticals position peaked at $11K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.